Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11473 posts found.

COVID-19 hospital cases expected to rise

July 4, 2022 Sales and Marketing

The CEO of UKSHA has said that the number of people being admitted to hospital with COVID-19 is expected to …
News

Liver injuries trigger clinical hold on Sanofi’s BTK drug

July 4, 2022 Sales and Marketing

The FDA has placed a partial clinical hold on Sanofi’s Phase III BTK inhibitor trial, following reports of drug-induced liver …
News

Knee replacement NHS policies on patient’s weight worsened health inequalities

July 4, 2022 Sales and Marketing

New research has found that weight/body mass index (BMI) policies introduced by NHS commissioning groups in England are associated with …
News

Long-Term Impact of Prophylactic Orladeyo on Hereditary Angioedema

July 4, 2022 Sales and Marketing

BioCryst Pharmaceuticals have shared new 96-week data from the open-label global randomised Phase III Apex-2 trial, and an independent six …
News

Telehealth clinics still offering abortion pills to people outside their states

June 27, 2022 Sales and Marketing

Telehealth abortion clinics have shared that they are still offering pills to people outside of their states, following the Supreme …
News

China NMPA approves TYVYT for gastric/gastroesophageal junction adenocarcinoma

June 27, 2022 Sales and Marketing

The National Medical Products Administration (NMPA) has approved the supplemental NDA for TYVYT (sintilimab injection) in combination with fluorouracil and …
News

NHS patients could have chance to travel for surgery

June 27, 2022 Sales and Marketing

NHS patients in England, who have been waiting over two years for surgery are being offered hospital treatment in certain …
News

CHMP recommends treatment for adults with chronic inflammatory disease

June 27, 2022 Sales and Marketing

The CHMP has recommended upadacitinib (RINVOQ® 15 mg, once daily) for approval, for the treatment of adults with active non-radiographic …
News

Monkeypox outbreak in Europe: UK guidance recommends close contacts isolate for 21 days

May 23, 2022 Sales and Marketing

The UK Health Security Agency (UKHSA) has released updated guidance on monkeypox now recommending that those who have had “unprotected …
News

Vaccine for rare but deadly mosquito-borne viruses in clinical trial

May 17, 2022 Sales and Marketing

Positive results for a vaccine for eastern equine encephalitis virus (EEEV), western equine encephalitis virus (WEEV), and Venezuelan equine encephalitis …
News

Eli Lilly’s diabetes treatment wins FDA approval

May 16, 2022 Sales and Marketing

Eli Lilly’s once-weekly dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist tirzepatide has won FDA approval.The FDA …
News

NHS prescription charges in England to be frozen for first time in 12 years

May 16, 2022 Sales and Marketing

The Department of Health has said that single prescription charges, which normally rise “in line with inflation”, will remain at …
News

Imfimzi for routine use on NHS England for patients with stage III unresectable lung cancer

May 16, 2022 Sales and Marketing

AstraZeneca has announced the NICE recommendation of Imfinzi (durvalumab) for routine use within NHS England as a monotherapy for the …
News

Researchers pinpoint reason for Sudden Infant Deaths

May 16, 2022 Sales and Marketing

Scientists from The Children’s Hospital Westmead in Sydney have discovered that babies who died of sudden infant death syndrome (SIDS) …
News

Evofem’s Phase III trial reveals fewer UTIs in women using Phexxi

May 9, 2022 Sales and Marketing

Evofem has announced new data from the Phase III AMPOWER clinical trial of Phexxi (lactic acid, citric acid, and potassium …
News

Latest content

Eisai and Biogen’s Leqembi launched for Alzheimer’s treatment in China

June 28, 2024

AbbVie’s Tepkinly gains positive CHMP opinion for follicular lymphoma treatment

June 28, 2024

IDEAYA Biosciences announces first-patient-in for phase 1 clinical trial evaluating IDE397 and Trodelvy combination in MTAP-deletion bladder cancer

June 27, 2024

Immunotherapy created at Roswell Park Comprehensive Cancer Center given expanded ODD by FDA

June 27, 2024

Abcuro completes enrolment for phase 2/3 IBM treatment trial

June 26, 2024